UniProt ID | TNK1_HUMAN | |
---|---|---|
UniProt AC | Q13470 | |
Protein Name | Non-receptor tyrosine-protein kinase TNK1 | |
Gene Name | TNK1 {ECO:0000312|EMBL:AAC99412.1} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 666 | |
Subcellular Localization |
Cytoplasm . Membrane Peripheral membrane protein . |
|
Protein Description | Involved in negative regulation of cell growth. Has tumor suppressor properties. Plays a negative regulatory role in the Ras-MAPK pathway. May function in signaling pathways utilized broadly during fetal development and more selectively in adult tissues and in cells of the lymphohematopoietic system. Could specifically be involved in phospholipid signal transduction.. | |
Protein Sequence | MLPEAGSLWLLKLLRDIQLAQFYWPILEELNVTRPEHFDFVKPEDLDGIGMGRPAQRRLSEALKRLRSGPKSKNWVYKILGGFAPEHKEPTLPSDSPRHLPEPEGGLKCLIPEGAVCRGELLGSGCFGVVHRGLWTLPSGKSVPVAVKSLRVGPEGPMGTELGDFLREVSVMMNLEHPHVLRLHGLVLGQPLQMVMELAPLGSLHARLTAPAPTPPLLVALLCLFLRQLAGAMAYLGARGLVHRDLATRNLLLASPRTIKVADFGLVRPLGGARGRYVMGGPRPIPYAWCAPESLRHGAFSSASDVWMFGVTLWEMFSGGEEPWAGVPPYLILQRLEDRARLPRPPLCSRALYSLALRCWAPHPADRPSFSHLEGLLQEAGPSEACCVRDVTEPGALRMETGDPITVIEGSSSFHSPDSTIWKGQNGRTFKVGSFPASAVTLADAGGLPATRPVHRGTPARGDQHPGSIDGDRKKANLWDAPPARGQRRNMPLERMKGISRSLESVLSLGPRPTGGGSSPPEIRQARAVPQGPPGLPPRPPLSSSSPQPSQPSRERLPWPKRKPPHNHPMGMPGARKAAALSGGLLSDPELQRKIMEVELSVHGVTHQECQTALGATGGDVVSAIRNLKVDQLFHLSSRSRADCWRILEHYQWDLSAASRYVLARP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
60 | Phosphorylation | RPAQRRLSEALKRLR HHHHHHHHHHHHHHH | 21.00 | 17192257 | |
68 | Phosphorylation | EALKRLRSGPKSKNW HHHHHHHCCCCCCCH | 65.13 | 20068231 | |
73 | Ubiquitination | LRSGPKSKNWVYKIL HHCCCCCCCHHHHHH | 62.04 | 29967540 | |
77 | Phosphorylation | PKSKNWVYKILGGFA CCCCCHHHHHHCCCC | 5.50 | 20090780 | |
88 | Ubiquitination | GGFAPEHKEPTLPSD CCCCCCCCCCCCCCC | 64.82 | 27667366 | |
91 | Phosphorylation | APEHKEPTLPSDSPR CCCCCCCCCCCCCCC | 53.01 | 28857561 | |
94 | Phosphorylation | HKEPTLPSDSPRHLP CCCCCCCCCCCCCCC | 54.56 | 18691976 | |
96 | Phosphorylation | EPTLPSDSPRHLPEP CCCCCCCCCCCCCCC | 28.33 | 25159151 | |
103 | Ubiquitination | SPRHLPEPEGGLKCL CCCCCCCCCCCCEEE | 43.52 | 22817900 | |
108 | Ubiquitination | PEPEGGLKCLIPEGA CCCCCCCEEECCCCC | 30.21 | 29967540 | |
139 | Phosphorylation | RGLWTLPSGKSVPVA CCEEECCCCCCCCEE | 63.06 | 24719451 | |
141 (in isoform 2) | Ubiquitination | - | 53.25 | 21890473 | |
141 (in isoform 1) | Ubiquitination | - | 53.25 | 21890473 | |
141 | Ubiquitination | LWTLPSGKSVPVAVK EEECCCCCCCCEEEE | 53.25 | 27667366 | |
160 | Phosphorylation | GPEGPMGTELGDFLR CCCCCCCCCHHHHHH | 23.06 | 30257219 | |
209 | Phosphorylation | GSLHARLTAPAPTPP CCEEEHHCCCCCCHH | 25.66 | - | |
214 | Phosphorylation | RLTAPAPTPPLLVAL HHCCCCCCHHHHHHH | 39.38 | - | |
235 | Phosphorylation | QLAGAMAYLGARGLV HHHHHHHHHHHCCHH | 7.81 | 20090780 | |
248 | Phosphorylation | LVHRDLATRNLLLAS HHCHHHHHHHHHHCC | 27.64 | 21712546 | |
255 | Phosphorylation | TRNLLLASPRTIKVA HHHHHHCCCCEEEEE | 18.19 | 22617229 | |
258 | Phosphorylation | LLLASPRTIKVADFG HHHCCCCEEEEECEE | 28.65 | - | |
260 | Ubiquitination | LASPRTIKVADFGLV HCCCCEEEEECEECE | 30.66 | 22817900 | |
260 (in isoform 1) | Ubiquitination | - | 30.66 | 21890473 | |
260 (in isoform 2) | Ubiquitination | - | 30.66 | 21890473 | |
261 | Ubiquitination | ASPRTIKVADFGLVR CCCCEEEEECEECEE | 5.66 | 23503661 | |
277 | Phosphorylation | LGGARGRYVMGGPRP CCCCCCCEECCCCCC | 9.52 | 20090780 | |
287 | Phosphorylation | GGPRPIPYAWCAPES CCCCCCCCEEECCHH | 17.29 | 20090780 | |
313 | Ubiquitination | VWMFGVTLWEMFSGG HHHHEEEEHHHHCCC | 3.20 | 27667366 | |
353 | Phosphorylation | PLCSRALYSLALRCW CHHHHHHHHHHHHHH | 10.72 | 20090780 | |
354 | Phosphorylation | LCSRALYSLALRCWA HHHHHHHHHHHHHHC | 14.17 | 24719451 | |
406 | Phosphorylation | METGDPITVIEGSSS ECCCCCEEEEECCCC | 22.33 | 22817900 | |
411 | Phosphorylation | PITVIEGSSSFHSPD CEEEEECCCCCCCCC | 15.26 | 18691976 | |
411 (in isoform 2) | Phosphorylation | - | 15.26 | 17192257 | |
418 (in isoform 2) | Ubiquitination | - | 62.52 | 21890473 | |
418 | Ubiquitination | SSSFHSPDSTIWKGQ CCCCCCCCCCEEECC | 62.52 | 23503661 | |
423 | Ubiquitination | SPDSTIWKGQNGRTF CCCCCEEECCCCCEE | 46.93 | 23503661 | |
458 | Phosphorylation | TRPVHRGTPARGDQH CCCCCCCCCCCCCCC | 17.46 | 28555341 | |
468 | Phosphorylation | RGDQHPGSIDGDRKK CCCCCCCCCCCCCHH | 23.20 | 25159151 | |
470 | Ubiquitination | DQHPGSIDGDRKKAN CCCCCCCCCCCHHCC | 55.42 | 27667366 | |
475 | Methylation | SIDGDRKKANLWDAP CCCCCCHHCCCCCCC | 43.32 | 115979821 | |
475 | Ubiquitination | SIDGDRKKANLWDAP CCCCCCHHCCCCCCC | 43.32 | 27667366 | |
497 | Phosphorylation | NMPLERMKGISRSLE CCCHHHHHHHCHHHH | 60.35 | 33259812 | |
500 | Phosphorylation | LERMKGISRSLESVL HHHHHHHCHHHHHHH | 25.20 | 30576142 | |
502 | Phosphorylation | RMKGISRSLESVLSL HHHHHCHHHHHHHCC | 29.69 | 19664994 | |
505 | Phosphorylation | GISRSLESVLSLGPR HHCHHHHHHHCCCCC | 33.38 | 22167270 | |
508 | Phosphorylation | RSLESVLSLGPRPTG HHHHHHHCCCCCCCC | 29.17 | 30278072 | |
514 | Phosphorylation | LSLGPRPTGGGSSPP HCCCCCCCCCCCCCH | 50.14 | 22167270 | |
518 | Phosphorylation | PRPTGGGSSPPEIRQ CCCCCCCCCCHHHHH | 42.84 | 22167270 | |
519 | Phosphorylation | RPTGGGSSPPEIRQA CCCCCCCCCHHHHHH | 47.99 | 19664994 | |
543 | Phosphorylation | LPPRPPLSSSSPQPS CCCCCCCCCCCCCCC | 33.67 | 18691976 | |
544 | Phosphorylation | PPRPPLSSSSPQPSQ CCCCCCCCCCCCCCC | 42.38 | 26657352 | |
545 | Phosphorylation | PRPPLSSSSPQPSQP CCCCCCCCCCCCCCC | 42.53 | 30576142 | |
546 | Phosphorylation | RPPLSSSSPQPSQPS CCCCCCCCCCCCCCC | 29.51 | 26657352 | |
550 | Phosphorylation | SSSSPQPSQPSRERL CCCCCCCCCCCHHCC | 49.85 | 18669648 | |
553 | Phosphorylation | SPQPSQPSRERLPWP CCCCCCCCHHCCCCC | 38.85 | 23312004 | |
558 | Ubiquitination | QPSRERLPWPKRKPP CCCHHCCCCCCCCCC | 52.09 | 29967540 | |
563 | Ubiquitination | RLPWPKRKPPHNHPM CCCCCCCCCCCCCCC | 69.86 | 29967540 | |
572 | Ubiquitination | PHNHPMGMPGARKAA CCCCCCCCCHHHHHH | 1.94 | 29967540 | |
577 | Ubiquitination | MGMPGARKAAALSGG CCCCHHHHHHHHHCC | 41.67 | 29967540 | |
582 | Phosphorylation | ARKAAALSGGLLSDP HHHHHHHHCCCCCCH | 26.53 | 21082442 | |
587 | Phosphorylation | ALSGGLLSDPELQRK HHHCCCCCCHHHHHH | 57.04 | 20068231 | |
612 | Phosphorylation | VTHQECQTALGATGG CCHHHHHHHHCCCCH | 35.19 | - | |
651 | Phosphorylation | CWRILEHYQWDLSAA HHHHHHHHCCCHHHH | 11.26 | 27642862 | |
659 | Phosphorylation | QWDLSAASRYVLARP CCCHHHHHHHHHCCC | 24.70 | - | |
661 | Phosphorylation | DLSAASRYVLARP-- CHHHHHHHHHCCC-- | 9.41 | 23911959 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
502 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TNK1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TNK1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TNK1_HUMAN | TNK1 | physical | 10873601 | |
DDX5_HUMAN | DDX5 | physical | 25852190 | |
ILF3_HUMAN | ILF3 | physical | 25852190 | |
1433S_HUMAN | SFN | physical | 25852190 | |
1433B_HUMAN | YWHAB | physical | 25852190 | |
1433E_HUMAN | YWHAE | physical | 25852190 | |
1433G_HUMAN | YWHAG | physical | 25852190 | |
1433F_HUMAN | YWHAH | physical | 25852190 | |
1433T_HUMAN | YWHAQ | physical | 25852190 | |
1433Z_HUMAN | YWHAZ | physical | 25852190 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96; SER-255; SER-411;SER-502; THR-514; SER-518 AND SER-543, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-502; SER-508; THR-514;SER-519 AND TYR-661, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60; SER-96; SER-255;TYR-277; SER-468; SER-502; THR-514; SER-519; SER-582 AND TYR-661, ANDMASS SPECTROMETRY. |